About ConcePTION

ConcePTION is a project funded by the Innovative Medicines Initiative, a private public partnership. The project was launched in April 2019.

We believe that we have an important societal obligation to radically and rapidly reduce uncertainty about the effects of medication used during pregnancy and breastfeeding to benefit women in making informed decisions about medications used before, during and after pregnancy.

Reporting medicine use in pregnancy

Did you use any medicines when you were pregnant? Here is how you and your health care provider can report what we call an exposure.

Ten principles for stakeholder engagement in the ConcePTION project

The ConcePTION project is building much-needed knowledge for women and health care professionals. To achieve our goal of building an ecosystem for medicine safety in pregnancy and breastfeeding, we need to engage with women, their partners, their doctors, pharmacists, midwives and nurses, the companies that develop medicines and the authorities that approve them and decide what becomes available to patients. Our goal is to work in an open and inclusive way, with the spirit of mutual respect and trust. Here is how we engage with stakeholders in an ethical way.

News

Apr
01
2021
Just like everyone else, pregnant women sometimes need to take medicines. Sometimes the reason has nothing to do with pregnancy, like headaches, allergies or chronic illness. Sometimes health problems start or get worse when a woman is pregnant, like diabetes, morning sickness or high blood pressure. Sometimes women take medicines before they know that they are pregnant. Often there is not enough evidence to give women trustworthy information about how her particular drug might affect the fetus. This is why women and health-care professionals should always report any medicines taken during pregnancy! Your information can help women make informed decisions about the benefits and risks of different treatments!  | READ MORE >>
Mar
08
2021
Women who are pregnant and breastfeeding mothers deserve to know if a medicine is safe. The Innovative Medicines Initiative ConcePTION project has a huge and difficult task ahead: Building a system for drug safety in pregnancy and breastfeeding. We bring universities, pharmaceutical companies and the authorities that approve medicines together in partnership: Joining forces to turn data into evidence!  | READ MORE >>
Mar
02
2021
To be able to say that it is safe for a pregnant woman to take a particular medicine, we need to know that the safety data is robust. The ConcePTION project is piecing European data together, building a system to generate evidence on medicine safety for pregnant and breastfeeding women. A recent report provides an inventory of the core elements that are needed to generate the evidence that is required. The report guides researchers in performing high quality and meaningful population-based studies: allowing women and their doctors to make informed decisions and weigh the benefits against the risks of treatments. | READ MORE >>

Twitter

Want to know how teratology information services work? Listen to Luke Richardson from @medsinpregnancy explain how the European Network of Teratology Information Services (ENTIS) monitors #medication use in #pregnancy 👇

https://youtu.be/Kr112TLrAsk

🧠💊 Seguridad de los medicamentos durante el embarazo para tratar migraña
Nuestra nueva publicación en el #JournalofNeurology @SpringerOpen @IMIConcePTION

https://idp.springer.com/authorize?response_type=cookie&client_id=springerlink&redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00415-021-10534-5%3Fwt_mc%3DInternal.Event.1.SEM.ArticleAuthorOnlineFirst%26utm_source%3DArticleAuthorOnlineFirst%26utm_medium%3Demail%26utm_content%3DAA_en_06082018%26ArticleAuthorOnlineFirst_20210402

The ConcePTION consortium

The project unites an unprecedented 88 organizations from 22 countries, including the European Medicines Agency, drug manufacturers, academia, public health organizations, and teratology networks to innovate new solutions to a decades-long public health issue.

OUR CONSORTIUM
»

The ConcePTION project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821520. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.